Brandywine Realty Trust Posts Q2 Loss, Tightens FFO Outlook, and Lifts Asset Sales Target
BDN sits 23% above its 52-week low of $2.47 on elevated volume (2.1× avg).
Summary
Brandywine Realty Trust reported a Q2 net loss of $(31.7) million and narrowed its 2026 FFO guidance to $0.53-$0.57 per share. The company raised its asset sales target to $305 million and plans $120-140 million in share buybacks and bond repurchases.
Key Events · Earnings and Guidance · BDN
-
Q2 Net Loss and FFO
The quarter produced a net loss of $(31.7) million, or $(0.18) per share, while FFO reached $23.6 million, or $0.13 per diluted share, down from $0.15 a year ago.
-
Narrowed 2026 FFO Guidance
Full-year FFO guidance was tightened to $0.53-$0.57 per share from $0.52-$0.58, and the loss per share outlook improved to $(0.45)-$(0.41) from $(0.76)-$(0.70).
-
Asset Sales Target Raised
The asset sales target was lifted to $305 million from $290 million; $208 million has closed, including an Austin sale at $151 million that netted $146.1 million.
-
Liquidity and Debt Reduction
Following recent sales, there is no outstanding balance on the $600 million unsecured line of credit, with $35 million cash on hand, and a $178 million construction loan has been repaid.
Analysis · BDN · Real Estate & Construction
A net loss of $(31.7) million, or $(0.18) per share, marked Brandywine Realty Trust's second quarter, while FFO came in at $0.13 per diluted share. The company narrowed its full-year FFO guidance to $0.53-$0.57 per share and raised the asset sales target to $305 million, with $208 million already closed. Proceeds have wiped out the balance on its $600 million credit line, and management is earmarking $120-140 million for share buybacks and bond repurchases in the second half of 2026. These results and capital allocation moves stand out against a backdrop of prior impairments and a recent credit facility extension.
At the time of this filing, BDN was trading at $3.04 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $528.1M. The 52-week trading range was $2.47 to $4.63. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.